BDTX- Black Diamond Therapeutics, Inc.

Name: Black Diamond Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Black Diamond Therapeutics, Inc. (BDTX) has 6 insiders with recent SEC Form 4 filings, including 12 buys and 5 sells. BDTX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Behbahani Ali	93.6K	$279.8K	-
Dir	Raman Prakash	37.1K	$111.0K	-
Dir	Dhingra Kapil	30.6K	$91.3K	-
Dir	Campbell Shannon	30.6K	$91.3K	-
Dir	Kulkarni Samarth	30.6K	$91.3K	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Oct 28, 2022	Biotech Growth N V53	10% Owner	Buy	364,652	$2.02	$736,185.98	+3.6%	+35.3%	-19.9%
Oct 21, 2022	Biotech Growth N V53	10% Owner	Buy	87,850	$1.51	$132,750.14	+1.8%	+93.0%	+32.9%
Oct 20, 2022	Biotech Growth N V53	10% Owner	Buy	131,423	$1.36	$179,120.05	+1.4%	+115.1%	+43.8%
Jun 29, 2022	Ni Fang77	See Remarks	Buy	25,000	$2.44	$61,017.50	+56.8%	-29.6%	+103.6%
Apr 28, 2022	Biotech Growth N V53	10% Owner	Buy	405,711	$2.61	$1,057,347.69	+4.6%	+33.5%	-45.6%
Apr 19, 2022	Biotech Growth N V53	10% Owner	Buy	300,000	$3.27	$980,580.00	+3.7%	-5.2%	-51.2%
Apr 13, 2022	Biotech Growth N V53	10% Owner	Buy	252,556	$3.48	$879,817.22	+3.3%	-14.9%	-56.7%
May 12, 2021	Hatzis-Schoch Brent82	See Remarks	Sale+OE	4,078	$27.42	$111,804.83	-12.5%	-64.8%	-93.4%
May 3, 2021	Roberts Christopher D.	Chief Scientific Officer	Sale+OE	2,500	$26.64	$66,602.25	-43.9%	-64.3%	-91.4%
Apr 12, 2021	Hatzis-Schoch Brent82	See Remarks	Sale+OE	4,078	$25.00	$101,950.00	-32.7%	-54.9%	-86.0%

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC